Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Wegovy 2.4 mg solution for injection in pre-filled pen
The George Institute
obstructive sleep apnea
1 trial -
Xingnaojing injection
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
1 trial -
Xolair
United Therapeutics Europe Ltd
Atopic Eczema
1 trial -
Xtandi - 40 mg soft capsules
The George Institute
PROSTATE CANCER
1 trial -
Yiqitongluo granule
The First People's Hospital of Lianyungang
Stroke
1 trial -
ZYNRELEF 200Mg-6Mg Extended-Release Solution
Heron Therapeutics
Post Operative Pain, Acute
1 trial -
Zithromax
United Therapeutics Europe Ltd
Asthma
1 trial -
Zoledronate
United Therapeutics Europe Ltd
Hip Fractures
1 trial -
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
a control group
The First People's Hospital of Lianyungang
Disorder of Stomach Function and Feeding Problems in Newborn
1 trial -
allopurinol
United Therapeutics Europe Ltd
Gout
1 trial -
artemether lumefantrine
United Therapeutics Europe Ltd
Uncomplicated Malaria
1 trial -
artemether-lumefantrine (ALN)
United Therapeutics Europe Ltd
Uncomplicated Malaria
1 trial -
aspirin 100mg/d therapy
The First People's Hospital of Lianyungang
Coronary Atherosclerosis
1 trial -
aspirin and clopidogrel
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
berberine hydrochloride
The First People's Hospital of Lianyungang
Hypertension
1 trial -
buprenorphine/naloxone
BICYCLE THERAPEUTICS
Opioid Use Disorder
1 trial -
butylphthalide(NBP)
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
combined fixed dose combination
United Therapeutics Europe Ltd
Tuberculosis
1 trial -
combined fixed dose combination
Gain Therapeutics
Tuberculosis
1 trial -
dapagliflozin
The First People's Hospital of Lianyungang
Diabetic Kidney Disease
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Aged
3 trials -
dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
dexmedetomidine hydrochloride for injection
The First People's Hospital of Lianyungang
Delirium
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources